Related Experiment Video
Updated: Jul 17, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
Polyglucosan body disease myopathy: an unusual presentation
Steve Vucic1, Roger Pamphlett, Edward J Wills
1Prince of Wales Medical Research Institute and Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia.
Abstract:
Polyglucosan body disease (PBD) is a slowly progressive adult-onset glycogen storage disorder that typically affects upper and lower neurons. Myopathy, as a complication of PBD has been reported rarely and clinically manifests as chronic limb-girdle muscle weakness. We report an unusual case of PBD myopathy presenting as an asymmetric motor syndrome that clinically overlapped with amyotrophic lateral sclerosis, further expanding the phenotype of this disorder.
Related Concept Videos
Type I Diabetes III: Clinical Manifestations
Hyperglycemia
Myasthenia Gravis ll: Pathophysiology
Proteoglycans
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes: